comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 23:45:26 - browse：265

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： ACA's risk program benefits Blue Cross Blue Shield insurers

entertainment

WSS

Create a giant ice tray with this foil pan hack to keep food cold this summer

Judge agrees to delay next hearing in Trump classified documents case

What it’s like to watch children die of measles

Just how do doctors, lawmakers, and the public define abortion?

The drug industry has found itself all alone in Washington

Headspace, Meta partner to launch VR meditation app for Quest

hotspot

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Amylyx ALS drug failure raises questions and concerns

23andMe had bad news about my health. I wish a person had delivered it

White House announces new plan to address the growing threat of xylazine in overdose crisis

How one medical school became remarkably diverse

Medicare wants to send $9 billion to 340B hospitals

ChatGPT in medicine: STAT answers readers' burning questions

Biden declares emergency in flood

Continuity nursing helped my family in our darkest PICU moments

How to bring more disabled researchers into academia

hotspot

Change Healthcare cyberattack prompts Medicare loan program

Biden declares emergency in flood

With psoriasis trial ahead, Alumis raises $259 million

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

focus

entertainment

entertainment